Condition
Pleural Mesothelioma clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Pleural Mesothelioma clinical trials that are recruiting, at sites in 8 countries (most in United States (2), Italy (2), Denmark (1)). By phase: Phase 1 (2), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 8Countries
Newest Pleural Mesothelioma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comprehensive multi-omics and functional profiling to fully characterize tumors | — | Palermo, Palermo and 1 other locations | Recruiting | Feb 11, 2026 |
| IDE892 alone and with IDE397 for MTAP-deleted advanced solid tumors | Phase 1 | Goodyear, Arizona and 22 other locations | Recruiting | Dec 11, 2025 |
| Skin tests to check biotherapy allergies in cancer patients | — | Angers | Recruiting | May 14, 2025 |
| Evaluating FAPI PET for diagnosing pleural mesothelioma | Phase 2 | Aalborg, Region North Jutland | Recruiting | Jan 23, 2025 |
| MT027 treatment for patients with pleural malignant tumors | Phase 1 | Beijing | Recruiting | Dec 10, 2024 |
| Oral Alintegimod with Ipilimumab followed by Nivolumab for advanced cancer | Phase 1/2 | Aurora, Colorado and 4 other locations | Recruiting | Apr 12, 2024 |
| Tracking lung cancer evolution through therapy | — | London | Recruiting | Nov 28, 2022 |
| Using Tumor Treating Fields for patients with pleural mesothelioma | — | Gauting, Bavaria and 22 other locations | Recruiting | Sep 14, 2022 |
All recruiting trials (8)
-
Comprehensive multi-omics and functional profiling to fully characterize tumors
This project tests whether detailed multi-omics and functional testing of tumor samples can better characterize high-risk blood and solid cancers for patients at participating centers.
-
IDE892 alone and with IDE397 for MTAP-deleted advanced solid tumors
This trial tests IDE892 by itself and combined with IDE397 in adults whose advanced solid tumors have MTAP deletion and have progressed after standard treatments.
-
Skin tests to check biotherapy allergies in cancer patients
We are testing skin tests to see if cancer patients treated with biotherapies have allergies or hypersensitivity to those drugs.
-
Evaluating FAPI PET for diagnosing pleural mesothelioma
This study is testing a new type of imaging called FAPI PET/CT to see if it can better diagnose pleural mesothelioma in patients compared to standard imaging methods.
-
MT027 treatment for patients with pleural malignant tumors
This study is testing a new treatment called MT027 for patients with pleural malignant tumors to see if it's safe and how well it works after they have already received standard treatment.
-
Oral Alintegimod with Ipilimumab followed by Nivolumab for advanced cancer
This study is testing if a new oral medication called Alintegimod, combined with two other cancer treatments, can help people with advanced solid tumors feel better and live longer.
-
Tracking lung cancer evolution through therapy
This study is trying to see how lung cancer changes during treatment in people with different types of the disease by collecting health information and samples over two years.
-
Using Tumor Treating Fields for patients with pleural mesothelioma
This study is testing how well Tumor Treating Fields can help patients with pleural mesothelioma who are not candidates for surgery and are receiving regular treatment.
Related topics
Quick answers
How many Pleural Mesothelioma clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (2 trials), Italy (2 trials), Denmark (1 trial), United Kingdom (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.